In vitro antimicrobial susceptibility of Brachyspira pilosicoli isolates from humans
- PMID: 12821498
- PMCID: PMC161862
- DOI: 10.1128/AAC.47.7.2354-2357.2003
In vitro antimicrobial susceptibility of Brachyspira pilosicoli isolates from humans
Abstract
The in vitro antimicrobial susceptibility of the anaerobic intestinal spirochete Brachyspira pilosicoli was investigated by an agar dilution method. Human (n = 123) and porcine (n = 16) isolates were susceptible to metronidazole, ceftriaxone, meropenem, tetracycline, moxifloxacin, and chloramphenicol; erythromycin and ciprofloxacin were not active. Resistance to amoxicillin and clindamycin varied. Amoxicillin susceptibility was restored by clavulanic acid.
Similar articles
-
Susceptibilities of Campylobacter jejuni isolates from Germany to ciprofloxacin, moxifloxacin, erythromycin, clindamycin, and tetracycline.Antimicrob Agents Chemother. 2003 Jul;47(7):2358-61. doi: 10.1128/AAC.47.7.2358-2361.2003. Antimicrob Agents Chemother. 2003. PMID: 12821499 Free PMC article.
-
Antimicrobial susceptibility testing of Brachyspira intermedia and Brachyspira pilosicoli isolates from Australian chickens.Avian Pathol. 2006 Feb;35(1):12-6. doi: 10.1080/03079450500465643. Avian Pathol. 2006. PMID: 16448937
-
Minimal inhibitory concentrations and time-kill determination of moxifloxacin against aerobic and anaerobic isolates.Int J Antimicrob Agents. 2002 Feb;19(2):111-8. doi: 10.1016/s0924-8579(01)00486-1. Int J Antimicrob Agents. 2002. PMID: 11850163
-
[Antimicrobial Susceptibility of Pathogenic Gram-positive Anaerobic Cocci: Data of a University Hospital in Turkey].Mikrobiyol Bul. 2020 Jul;54(3):404-417. doi: 10.5578/mb.69556. Mikrobiyol Bul. 2020. PMID: 32755517 Turkish.
-
Antianaerobic activity of moxifloxacin compared with that of ofloxacin, ciprofloxacin, clindamycin, metronidazole and beta-lactams.Int J Antimicrob Agents. 2002 Nov;20(5):366-74. doi: 10.1016/s0924-8579(02)00209-1. Int J Antimicrob Agents. 2002. PMID: 12431872
Cited by
-
Intestinal spirochetosis mimicking inflammatory bowel disease in children.BMC Pediatr. 2012 Oct 16;12:163. doi: 10.1186/1471-2431-12-163. BMC Pediatr. 2012. PMID: 23066991 Free PMC article. Review.
-
Human intestinal spirochetosis--a review.Ger Med Sci. 2010 Jan 7;8:Doc01. doi: 10.3205/000090. Ger Med Sci. 2010. PMID: 20200654 Free PMC article. Review.
-
Genetic and biochemical characterization of OXA-63, a new class D beta-lactamase from Brachyspira pilosicoli BM4442.Antimicrob Agents Chemother. 2008 Apr;52(4):1264-8. doi: 10.1128/AAC.00684-07. Epub 2008 Jan 22. Antimicrob Agents Chemother. 2008. PMID: 18212108 Free PMC article.
-
Brachyspira pilosicoli bloodstream infections: case report and review of the literature.Ann Clin Microbiol Antimicrob. 2008 Sep 25;7:19. doi: 10.1186/1476-0711-7-19. Ann Clin Microbiol Antimicrob. 2008. PMID: 18817558 Free PMC article. Review.
-
Answer to February 2021 Photo Quiz.J Clin Microbiol. 2021 Jan 21;59(2):e00401-20. doi: 10.1128/JCM.00401-20. Print 2021 Jan 21. J Clin Microbiol. 2021. PMID: 33479054 Free PMC article. No abstract available.
References
-
- Applebaum, P. C. 1995. Quinolone activity against anaerobes: microbiological aspects. Drugs 49(Suppl. 2):76-80. - PubMed
-
- Crucioli, V., and A. Busuttil. 1981. Human intestinal spirochaetosis. Scand. J. Gastroenterol. Suppl. 70:177-179. - PubMed
-
- Duhamel, G. E., J. M. Kinyon, M. R. Mathiesen, D. P. Murphy, and D. Walter. 1998. In vitro activity of four antimicrobial agents against North American isolates of porcine Serpulina pilosicoli. J. Vet. Diagn. Investig. 10:350-356. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases